Kevzara 00024-5920
Generic: Sarilumab
Product NDC
00024-5920- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 22, 2017
- Listing Expires
- December 31, 2027
- Application
- BLA761037
Need to source Kevzara? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sarilumab | 150 mg/1.14mL |
Drug Class
Interleukin-6 Receptor Antagonist [EPC]Interleukin 6 Receptor Antagonists [MoA]Interleukin-6 Receptor Antagonist [EPC]
Packaging Options(2)
2 SYRINGE in 1 PACKAGE (0024-5920-01) / 1.14 mL in 1 SYRINGE (0024-5920-00)
2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRINGE